Navigation Links
Binex and MaxCyte Collaborate on Cancer Immunotherapy Research
Date:11/30/2007

BUSAN, South Korea and GAITHERSBURG, Md., Nov. 30 /PRNewswire/ -- Binex (KOSDAQ: 053030) and MaxCyte, Inc. announced today the signing of a Sponsored Research Agreement to evaluate MaxCyte's GMP-compliant cell loading technology for use in closed-system manufacturing of Binex's cell-based cancer immunotherapies. Upon completion of the research studies, the agreement provides Binex an option to license MaxCyte's technology for clinical and commercial use in Korea. Financial terms were not disclosed.

"Based upon its impressive capabilities, we believe MaxCyte's cell loading technology can be an important component of our closed system," said Baek Chun Lee, Ph.D., Binex's Chairman. "Our immunotherapy product is currently undergoing review by the Korean FDA for colorectal and non-small cell lung cancers and clinical studies are in progress for breast and gastrointestinal cancers. We expect cell immunotherapies to continue to be a core business for Binex. As we advance this therapy, we are developing a closed system manufacturing process which will allow us to improve scalability and reduce cost for making inroads into world markets. We believe MaxCyte's technology can contribute significantly as we expand this product toward new indications."

"We are extremely pleased to be working with Binex to advance their promising cancer vaccine. Our technology has been shown to be uniquely effective, capable of producing cell-based therapeutics that are highly reproducible, with the scalability and efficiency needed for commercial use," said Douglas Doerfler, President and CEO of MaxCyte. "Binex's readiness to partner with MaxCyte validates both the enablement of our cell loading technology platform and their leadership as a life sciences company."

About Binex

Binex Co., Ltd. is a publicly traded specialized pharmaceutical company located in Busan, Korea developing a broad range of pharmaceutical products such as nutrients and vitamin com
'/>"/>

SOURCE MaxCyte, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
2. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
3. Rice, Nanyang Tech collaborate on sustainable nanoelectronics
4. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
5. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
6. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
7. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano
8. New Pharmacogenomic Approach: 454 Life Sciences and Perlegen to Collaborate in Drug Response Sequencing Study
9. Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire-FirstCall/--IES(Nasdaq: IESC ),aleadingnatio...servicesforthecommercial,industrialandresidentialm...phasbeenawardedacontractfromManhattanTorconJVtoins...BSL-4)replacementfacilityattheU.S.ArmyMedicalResea...trickinFrederick,Md. ,, ThenewUSAMRIIDreplaceme...
(Date:11/24/2009)....24/PRNewswire/--Twomoreprestigiousuniversitieshav...boardandcareerssiteforlifescienceprofessionals. ,...ofthejobboard,joining28othermajorlifesciencetraini...nter.com ,isonlyforpost-graduatesinthelifesciences...eInternet,BioCareerCenteristheonlyonethatserveslif...
(Date:11/24/2009)...wswire-FirstCall/--Sigma-AldrichCorporation(Nasdaq...Tuesday,December1stat1:45PMGMTinLondon,7:45AMUS/CS...vertheInternetavailableat http://inve s tor.sig...icontoaccessthisfile. ,, AboutSigma-Aldrich: ...gycompany.Itschemicalandbiochemicalproductsandkits...
(Date:11/24/2009)...wswire-Asia/--NODPharmaceuticalsInc.announced,theU...tapplicationfor,itsnano-particleoraldeliveryorNODt...pproachtoincorporatepeptidesor,proteinsintobio-adh...erwiseadministeredasinjections.NODtechnologyisapla...ardrugssuchasinsulin,interferon,growthhormone,exe...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...YKJAVIK, Iceland, Aug. 29 deCODE genetics,(Nasdaq... webcast of deCODE,CEO Kari Stefansson,s presentat...e Conference. The presentation will be delivered ... Seasons, Boston. The webcast can be accessed,thro...//www.decode.com, and those,interested in listeni...
...MBRIDGE, Mass., Aug. 29 Millennium,Pharmaceutical...presentation,at the Thomas Weisel Partners 2007 He...e accessed by visiting the Investors section of th... (Logo: http://www.newscom.com/cgi-bin/prnh/19991...nt events, clinical pipeline updates,and upcoming ...
...ILADELPHIA, Aug. 29 eResearchTechnology,Inc. (eRT...ized,electrocardiographic (ECG) collection and int...ael J. McKelvey, the Company,s President and,Chief...,s Chief Financial,Officer, will present at the Th...tern on September 5, 2007 in the Phillips Room at ...
Other Biology Technology:Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation 2eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th 2eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th 3
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
(Date:11/23/2009)...t research suggests that a common oral bacterium m...ort by Nichols et al, "Unique Lipids from a Common...ands Capable of Enhancing Autoimmunity," appears i... of Pathology . , Multiple sclerosis (MS), a dis... spinal cord, affects nearly 1 in 700 people in th...
(Date:11/23/2009)... producing some of the highest resolution images o...ts have a deeper understanding how biomolecules ma...ad to a new treatment for kidney stones using biom...ov. 23 online edition of the journal Proceedings ... peptides interact with mineral surfaces by accele...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Existing Drug May Lead to ALS Treatment 59797 1Existing Drug May Lead to ALS Treatment 59797 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6
...RANSAS, TexasBacterial communities endemic to heal...d type of natural and man-made dissolved organic m...versity of Texas at Austin Marine Science Institut... , Healthy corals naturally exude a surrounding m...ria exists. Recent studies have indicated that so...
...DGE, Tenn., March 4, 2008 -- Latin American nation...world markets in coming decades, according to an O...ly. , The report, Biofuel Feedstock Assessment fo...rch conducted in support of a larger study of Worl...n U.S. Imports by the Department of Energy. The OR...
...rd minimum of Arctic sea ice, new species in the A...t climate these are only some of the results of t...r Year 2007/08. From March 10 14, 2008 the most i...he frame of the 23rd International Polar Meeting o...n to scientific highlights, also student and schoo...
Other Biology News:Dissolved organic matter in the water column may influence coral health 2Imports from Latin America may help US meet energy goals, study finds 2Imports from Latin America may help US meet energy goals, study finds 3Half time in the International Polar Year 2007-2008 2
...nd is causing shortages in your laboratory or fell...an cause unwanted distractions, problems and delay... work and endeavour! Bring us your idea and let us...k under ISO 9001 quality assurance in design, deve...
...rons are cytopathic effect inhibition assays, also...include; tissue culture supernatents; serum from P...ays, one unit is defined as the quantity of interf...hic effect of viral infection by 50%. All standa...
...ia virus is a type I eukaryotic topoisomerase that...urns (also called right- and left-handed supercoil...reaction is a covalently closed, circular DNA with...A Topoisomerase I does not absolutely require Mg 2...
...ia virus is a type I eukaryotic topoisomerase that...urns (also called right- and left-handed supercoil...reaction is a covalently closed, circular DNA with...A Topoisomerase I does not absolutely require Mg 2...
Biology Products: